FMO5 and lung carcinoma: Imidazo [1,2-a] pyridine-based derivatives evidently stimulate cytotoxicity by notably augmenting NADPH oxidase activity, which leads to the stimulation of ROS-mediated apoptosis in A549 lung cancer cells [45].